Risk for second malignancies in non-Hodgkin’s lymphoma survivors: a meta-analysis

PIRANI M.; MARCHESELLI R.; MARCHESELLI L.; BARI A.; FEDERICO M.; SACCHI S.

Art

J-GLOBAL ID：201102268475482703 Reference number：11A1464724

Risk for second malignancies in non-Hodgkin’s lymphoma survivors: a meta-analysis

非Hodgkinリンパ腫生存者における二次性悪性腫瘍のリスク:メタ分析

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=11A1464724&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A1464724&from=J-GLOBAL&jstjournalNo=W0107A") }}

Author (6)： , , , , ,
Material：
Volume： 22 Issue： 8 Page： 1845-1858 Publication year： Aug. 2011
JST Material Number： W0107A ISSN： 0923-7534 CODEN： ANONE2 Document type： Article
Article type：原著論文 Country of issue： United Kingdom (GBR) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A1464724&from=J-GLOBAL&jstjournalNo=W0107A") }}

Blood cell tumors(=neoplasms) , Carcinogenic mechanisms and factors

Reference (94)：

Fisher RI, LeBlanc M, Press OW et al. New treatment options have changed the survival of patients with follicular lymphoma. J Clin Oncol 2005; 23: 8447-8452.
Marcus R, Imrie K, Solal-Celigny P et al. Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma. J Clin Oncol 2008; 26: 4579-4586.
Sacchi S, Pozzi S, Marcheselli L et al. Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients. Cancer 2007; 109: 2077-2082.
Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-242.
Habermann TM, Weller EA, Morrison VA et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 2006; 24: 3121-3127.

ｍore...

, , , ,

Return to Previous Page